Daito Pharmaceutical Balance Sheet

Financials in millions JPY. Fiscal year is June - May.

Millions JPY. Fiscal year is Jun - May.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 31, 2026	May '25 May 31, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022
Cash & Equivalents	954	2,207	2,727	3,607	4,381
Cash & Short-Term Investments	954	2,207	2,727	3,607	4,381
Cash Growth	-56.77%	-19.07%	-24.40%	-17.67%	29.92%
Accounts Receivable	18,955	20,254	15,441	17,654	16,146
Other Receivables	-	-	1,292	-	-
Receivables	18,955	20,254	16,733	17,654	16,146
Inventory	16,439	18,412	20,890	18,238	16,820
Other Current Assets	281	835	1,110	1,164	562
Total Current Assets	36,629	41,708	41,460	40,663	37,909
Property, Plant & Equipment	30,676	31,826	31,972	25,837	23,116
Long-Term Investments	4,092	3,579	3,464	3,169	2,958
Other Intangible Assets	1,712	531	490	377	386
Long-Term Deferred Tax Assets	181	359	320	504	570
Other Long-Term Assets	1	1	2	2	-
Total Assets	73,291	78,004	77,708	70,552	64,939
Accounts Payable	7,417	8,266	8,699	8,172	7,864
Accrued Expenses	1,184	1,086	1,051	1,091	1,170
Short-Term Debt	-	-	-	69	11
Current Portion of Long-Term Debt	2,815	3,099	2,099	1,429	1,189
Current Portion of Leases	506	358	275	15	-
Current Income Taxes Payable	1,849	3,348	4,681	4,288	3,319
Other Current Liabilities	227	892	1,700	364	516
Total Current Liabilities	13,998	17,049	18,505	15,428	14,069
Long-Term Debt	3,753	6,569	4,669	3,368	2,247
Long-Term Leases	2,220	1,859	1,676	77	-
Pension & Post-Retirement Benefits	33	169	320	497	755
Long-Term Deferred Tax Liabilities	65	30	32	31	32
Other Long-Term Liabilities	284	261	242	180	165
Total Liabilities	20,353	25,937	25,444	19,581	17,268
Common Stock	7,186	7,186	7,186	7,186	7,031
Additional Paid-In Capital	7,072	7,072	7,072	7,072	6,917
Retained Earnings	36,970	37,179	37,087	35,006	32,338
Treasury Stock	-128	-749	-990	-124	-13
Comprehensive Income & Other	1,792	1,315	1,713	1,532	1,031
Total Common Equity	52,892	52,003	52,068	50,672	47,304
Minority Interest	46	64	196	299	367
Shareholders' Equity	52,938	52,067	52,264	50,971	47,671
Total Liabilities & Equity	73,291	78,004	77,708	70,552	64,939
Total Debt	9,294	11,885	8,719	4,958	3,447
Net Cash (Debt)	-8,340	-9,678	-5,992	-1,351	934
Net Cash Per Share	-283.53	-318.14	-190.94	-42.68	30.50
Filing Date Shares Outstanding	28.78	29.99	30.59	31.61	31.7
Total Common Shares Outstanding	28.78	29.99	30.59	31.61	31.43
Working Capital	22,631	24,659	22,955	25,235	23,840
Book Value Per Share	1837.63	1734.24	1702.33	1603.24	1504.87
Tangible Book Value	51,180	51,472	51,578	50,295	46,918
Tangible Book Value Per Share	1778.15	1716.53	1686.31	1591.31	1492.59
Order Backlog	-	5,840	5,417	5,223	7,585